Insurance barriers and inequalities in health care access: evidence from dual practice
We investigate access disparities in pharmaceutical care among German patients with type 2 diabetes, focusing on differences between public and private health insurance schemes. The primary objectives include ...
Source: Health Economics Review - Category: Health Management Authors: Eva Goetjes and Katharina E. Blankart Tags: Research Source Type: research
More News: Diabetes | Diabetes Type 2 | Economics | Endocrinology | Germany Health | Health Insurance | Health Management | Insurance